Juan Pablo Dueñas
Research Subjects
Juan Pablo Dueñas has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Simón Duque Fisher
Hospital Pablo Tobón Uribe
4 shared publications - Alvaro Sanabria
Department of Surgery, School of Medicine, Universidad de Antioquia, Medellín, Colombia
2 shared publications Ana Voogd
Department of Head and Neck Surgery, Hospital Universitario Austral, Buenos Aires, Argentina
2 shared publications- Ana Voogd
Departamento de Cirugía de Cabeza y Cuello, Hospital Universitario Austral, Buenos Aires, Argentina
2 shared publications Carlos Simón Duque
Universidad Militar Nueva Granada Bogotá DC Colombia
2 shared publicationsErivelto Martinho Volpi
Department of Head and Neck Surgery, Oncology Center, Oswaldo Cruz German Hospital, São Paulo, Brazil
2 shared publications
Latest Publications
- 6 August 2026
- Published by SAGE Publications in Thyroid®
- Vol. 36 (10) , 1053-1062
Early Outcomes of Thermal Ablation for Low-Risk Papillary Thyroid Cancer: A Multicenter Study from Latin American Interventional Thyroidology Association (LAITA)
Background: Thermal ablation has emerged as a minimally invasive alternative for low-risk papillary thyroid cancer (PTC). However, data from Latin America remain scarce. This multicenter study evaluated the early efficacy and safety of thermal ablation for low-risk PTC across multiple Latin American centers. Methods: Retrospective cohort study including 251 patients with 252 tumors (T1N0M0 PTC, ≤2 cm) treated with ultrasound-guided radiofrequency ablation (RFA) at 12 centers across 6 Latin American countries from January 2019 to June 2025. Primary outcomes were complete tumor disappearance, disease progression, and complications. Results: Median age was 45.5 years (interquartile range [IQR]: 36.5–56), with 74.2% female patients. Median tumor size was 6.7 mm (IQR: 5–8); 92.1% were T1a (≤10 mm). After a median follow-up of 18 months (IQR 12–24, range 12–72), complete tumor disappearance was achieved in 89.7% overall (226/252), reaching 97.0% in tumors with ≥18 months and 100% with ≥36 months of follow-up. Tumor persistence was observed in 10.3% (26/252) at last follow-up, with no lymph node or distant metastases. The overall complication rate was 2.4% (6/252), all consisting of transient dysphonia. On multivariable analysis, tumor size >10 mm was independently associated with a lower likelihood of complete tumor disappearance (adjusted odds ratios [OR] 0.23 [CI: 0.07–0.78]), whereas follow-up >12 months was associated with a higher likelihood (adjusted OR: 11.33 [CI: 3.61–35.6]). A supplementary post hoc analysis suggested a possible association between higher general operator volume (≥250 RFA procedures) and complete disappearance. Conclusions: RFA demonstrates excellent efficacy and acceptable safety for T1a low-risk PTC in Latin American patients, with outcomes comparable with other series, supporting it as a viable alternative to surgery or active surveillance in selected patients. Efficacy for T1b tumors was lower and based on a small number of cases; ablation of T1b disease should therefore be regarded as requiring further investigation, ideally within the framework of a clinical trial.
- 6 August 2026
- Published by SAGE Publications in Thyroid®
- Vol. 36 (10) , 1053-1062
Early Outcomes of Thermal Ablation for Low-Risk Papillary Thyroid Cancer: A Multicenter Study from Latin American Interventional Thyroidology Association (LAITA)
Background: Thermal ablation has emerged as a minimally invasive alternative for low-risk papillary thyroid cancer (PTC). However, data from Latin America remain scarce. This multicenter study evaluated the early efficacy and safety of thermal ablation for low-risk PTC across multiple Latin American centers. Methods: Retrospective cohort study including 251 patients with 252 tumors (T1N0M0 PTC, ≤2 cm) treated with ultrasound-guided radiofrequency ablation (RFA) at 12 centers across 6 Latin American countries from January 2019 to June 2025. Primary outcomes were complete tumor disappearance, disease progression, and complications. Results: Median age was 45.5 years (interquartile range [IQR]: 36.5–56), with 74.2% female patients. Median tumor size was 6.7 mm (IQR: 5–8); 92.1% were T1a (≤10 mm). After a median follow-up of 18 months (IQR 12–24, range 12–72), complete tumor disappearance was achieved in 89.7% overall (226/252), reaching 97.0% in tumors with ≥18 months and 100% with ≥36 months of follow-up. Tumor persistence was observed in 10.3% (26/252) at last follow-up, with no lymph node or distant metastases. The overall complication rate was 2.4% (6/252), all consisting of transient dysphonia. On multivariable analysis, tumor size >10 mm was independently associated with a lower likelihood of complete tumor disappearance (adjusted odds ratios [OR] 0.23 [CI: 0.07–0.78]), whereas follow-up >12 months was associated with a higher likelihood (adjusted OR: 11.33 [CI: 3.61–35.6]). A supplementary post hoc analysis suggested a possible association between higher general operator volume (≥250 RFA procedures) and complete disappearance. Conclusions: RFA demonstrates excellent efficacy and acceptable safety for T1a low-risk PTC in Latin American patients, with outcomes comparable with other series, supporting it as a viable alternative to surgery or active surveillance in selected patients. Efficacy for T1b tumors was lower and based on a small number of cases; ablation of T1b disease should therefore be regarded as requiring further investigation, ideally within the framework of a clinical trial.
- Open Access
- 28 November 2025
- Vol. 69 (6) , e250129
The clinical utility of thermal ablation procedures in thyroid nodules: Latin American Thyroid Society (LATS) surgical affairs committee expert opinion. Part 2.
Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread adoption of TA modalities, now used not only for symptomatic benign thyroid nodules (BTN), including autonomously functioning thyroid nodules (AFTN), but also for low-risk papillary thyroid microcarcinoma (PTMC). The evidence presented in this consensus has demonstrated the comparable effectiveness of TA to surgery for BTN in terms of volume reduction percentage (VRP), resolution of symptoms, and cosmetic concerns. Similarly, TA could be considered a suitable option for treating AFTN when surgery or radioactive iodine (RAI) is contraindicated, or when patients decline either of these options, offering a comparable effectiveness profile to RAI in terms of normalizing thyroid-stimulating hormone levels. For PTMC, TA may serve as an alternative for patients at high surgical risk or those who decline surgery, showing comparable outcomes to surgery in terms of local recurrence and lymph node metastasis. Additionally, TA exhibits a superior safety profile compared to surgery or RAI, characterized by reduced complications, preservation of thyroid function, and shorter hospitalization durations. While evidence on cost-effectiveness in Latin America remains limited, studies conducted in other countries support the implementation of TA as a first-line treatment option for BTN. The lack of economic assessment specific to AFTN complicates its consideration as a primary treatment choice; however, the effectiveness and safety profile suggest that the widespread adoption of TA as a first-line therapy could be considered for carefully selected patients diagnosed with AFTN or PTMC. The Surgical Affairs Committee of the Latin American Thyroid Society conducted a comprehensive review of TA as a primary treatment modality for benign, autonomously functioning, and malignant thyroid nodules to ensure its appropriate utilization in the field.
- 28 November 2025
- Vol. 69 (6) , e250129
Open AccessThe clinical utility of thermal ablation procedures in thyroid nodules: Latin American Thyroid Society (LATS) surgical affairs committee expert opinion. Part 2.
Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread adoption of TA modalities, now used not only for symptomatic benign thyroid nodules (BTN), including autonomously functioning thyroid nodules (AFTN), but also for low-risk papillary thyroid microcarcinoma (PTMC). The evidence presented in this consensus has demonstrated the comparable effectiveness of TA to surgery for BTN in terms of volume reduction percentage (VRP), resolution of symptoms, and cosmetic concerns. Similarly, TA could be considered a suitable option for treating AFTN when surgery or radioactive iodine (RAI) is contraindicated, or when patients decline either of these options, offering a comparable effectiveness profile to RAI in terms of normalizing thyroid-stimulating hormone levels. For PTMC, TA may serve as an alternative for patients at high surgical risk or those who decline surgery, showing comparable outcomes to surgery in terms of local recurrence and lymph node metastasis. Additionally, TA exhibits a superior safety profile compared to surgery or RAI, characterized by reduced complications, preservation of thyroid function, and shorter hospitalization durations. While evidence on cost-effectiveness in Latin America remains limited, studies conducted in other countries support the implementation of TA as a first-line treatment option for BTN. The lack of economic assessment specific to AFTN complicates its consideration as a primary treatment choice; however, the effectiveness and safety profile suggest that the widespread adoption of TA as a first-line therapy could be considered for carefully selected patients diagnosed with AFTN or PTMC. The Surgical Affairs Committee of the Latin American Thyroid Society conducted a comprehensive review of TA as a primary treatment modality for benign, autonomously functioning, and malignant thyroid nodules to ensure its appropriate utilization in the field.
- 18 June 2025
- Published by Springer Nature
- p. 157-166
Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules
- 18 June 2025
- Published by Springer Nature
- p. 157-166
Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules
- Open Access
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 59 (6) , 01-18
The clinical utility of thermal ablation procedures in thyroid nodules: Latin American Thyroid Society (LATS) surgical affairs committee expert opinion. Part 2
Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread [...] ABSTRACT Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 59 (6) , 01-18
Open AccessThe clinical utility of thermal ablation procedures in thyroid nodules: Latin American Thyroid Society (LATS) surgical affairs committee expert opinion. Part 2
Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread [...] ABSTRACT Thermal ablation (TA) encompasses various options such as radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). The fundamental principle of these techniques involves generating heat to induce coagulative necrosis of the nodules. The rising incidence of thyroid nodules, most of which are benign, has highlighted the importance of minimally invasive methods that effectively control symptoms, address cosmetic concerns, and achieve volume reduction. The potential complications associated with surgical interventions have driven the widespread
- Open Access
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (2) , 1-14
Use of technologies in thyroid surgery: Latin American Thyroid Society Surgical Affairs Committee Expert Opinion. Part 1
Thyroidectomyis the most frequent endocrine surgical treatment for problems such as goiter, thyroid cancer, and Graves’ disease. The global incidence of goiter ranges from 5%-20%, with a notably high frequency in less wealthy countries, and the incidence of thyroid cancer is on the rise due to the greater use of diagnostic imaging. Despite medical options, surgery remains essential. Surgical advancements such as blood vessel sealing technology, intraoperative laryngeal nerve neuromonitoring (IONM), remote access surgery, and parathyroid fluorescence have transformed [...] ABSTRACT Thyroidectomyis the most frequent endocrine surgical treatment for problems such as goiter, thyroid cancer, and Graves’ disease. The global incidence of goiter ranges from 5%-20%, with a notably high frequency in less wealthy countries, and the incidence of thyroid cancer is on the rise due to the greater use of diagnostic imaging. Despite medical options, surgery remains essential. Surgical advancements such as blood vessel sealing technology, intraoperative laryngeal nerve neuromonitoring (IONM), remote access surgery, and parathyroid fluorescence have transformed
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (2) , 1-14
Open AccessUse of technologies in thyroid surgery: Latin American Thyroid Society Surgical Affairs Committee Expert Opinion. Part 1
Thyroidectomyis the most frequent endocrine surgical treatment for problems such as goiter, thyroid cancer, and Graves’ disease. The global incidence of goiter ranges from 5%-20%, with a notably high frequency in less wealthy countries, and the incidence of thyroid cancer is on the rise due to the greater use of diagnostic imaging. Despite medical options, surgery remains essential. Surgical advancements such as blood vessel sealing technology, intraoperative laryngeal nerve neuromonitoring (IONM), remote access surgery, and parathyroid fluorescence have transformed [...] ABSTRACT Thyroidectomyis the most frequent endocrine surgical treatment for problems such as goiter, thyroid cancer, and Graves’ disease. The global incidence of goiter ranges from 5%-20%, with a notably high frequency in less wealthy countries, and the incidence of thyroid cancer is on the rise due to the greater use of diagnostic imaging. Despite medical options, surgery remains essential. Surgical advancements such as blood vessel sealing technology, intraoperative laryngeal nerve neuromonitoring (IONM), remote access surgery, and parathyroid fluorescence have transformed
- 29 July 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5231-5238
The Influence of Impedance on the Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules
Objective: Radiofrequency ablation (RFA) uses the heat generated by a high‐frequency alternating electric current, and according to Ohm's and Joule's law, the delivered current is inversely proportional to the circuit impedance. The primary objective of this study was to investigate whether tissue impedance during radiofrequency ablation (RFA) for benign thyroid nodules is related to the degree of volume reduction.Methods: This observational study included consecutive patients treated with RFA for benign thyroid nodules from February 2020 to August 2023. Technical effectiveness was defined as a volume reduction percentage (VRP) >75% at 6 months after the treatment. Multivariate logistic regression analyses were performed to identify the potential role of clinical factors and changes in tissue impedance on technique effectiveness.Results: Totally 72 patients were included with 73 benign thyroid nodules. Maximal impedance peaks reached 75% at bivariate analysis. These cutoff points were exploratory, as no existing literature suggests these variables are related to the degree of volume reduction. After adjusting for age, volume, and composition, significant associations were found for mean electrical impedance in the multivariate analysis (OR = 4.86 [confidence interval [CI] 1.29–18.26], p = 0.019). The energy adjusted by volume (delivered energy) was not associated with a VRP >75% (p = 0.7746).Conclusions: This study suggests that a mean procedural impedance </= 300 Ω is related to the effectiveness of RFA as measured by VRP. Additional prospective and randomized studies are needed to compare electrical parameters with VRP.Level of Evidence: 3 Laryngoscope, 134:5231–5238, 2024
- 29 July 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5231-5238
The Influence of Impedance on the Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules
Objective: Radiofrequency ablation (RFA) uses the heat generated by a high‐frequency alternating electric current, and according to Ohm's and Joule's law, the delivered current is inversely proportional to the circuit impedance. The primary objective of this study was to investigate whether tissue impedance during radiofrequency ablation (RFA) for benign thyroid nodules is related to the degree of volume reduction.Methods: This observational study included consecutive patients treated with RFA for benign thyroid nodules from February 2020 to August 2023. Technical effectiveness was defined as a volume reduction percentage (VRP) >75% at 6 months after the treatment. Multivariate logistic regression analyses were performed to identify the potential role of clinical factors and changes in tissue impedance on technique effectiveness.Results: Totally 72 patients were included with 73 benign thyroid nodules. Maximal impedance peaks reached 75% at bivariate analysis. These cutoff points were exploratory, as no existing literature suggests these variables are related to the degree of volume reduction. After adjusting for age, volume, and composition, significant associations were found for mean electrical impedance in the multivariate analysis (OR = 4.86 [confidence interval [CI] 1.29–18.26], p = 0.019). The energy adjusted by volume (delivered energy) was not associated with a VRP >75% (p = 0.7746).Conclusions: This study suggests that a mean procedural impedance </= 300 Ω is related to the effectiveness of RFA as measured by VRP. Additional prospective and randomized studies are needed to compare electrical parameters with VRP.Level of Evidence: 3 Laryngoscope, 134:5231–5238, 2024
- Open Access
- 10 April 2023
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 10 (2)
Hiperaldosteronismo causado por quiste adrenal
Introducción: los quistes adrenales son poco comunes, en especial los de tipo funcional, ya que solo se hallaron 3 casos reportados en la literatura. Objetivo: presentar un caso clínico de un paciente con hiperaldosteronismo asociado a un quiste adrenal. Presentación del caso: paciente masculino de 39 años con hipertensión arterial desde los 38 años al cual se le deciden realizar estudios de hipertensión secundaria, encontrando como hallazgo positivo hiperaldosteronismo primario en la evaluación inicial. Se realizó confirmación bioquímica con test de supresión con solución con un posterior hallazgo de adenoma adrenal izquierdo de baja densidad en TAC de abdomen contrastado, por lo que fue llevado a que se le realizara una adrenalectomía laparoscópica con curación bioquímica, según evaluación a los cuatro meses postoperatorios sin uso de antihipertensivos. Discusión y conclusión: los quistes adrenales generalmente se presentan unilateralmente con diferentes categorías histopatológicas, además, lo usual es que sean no funcionales. El hiperaldosteronismo primario es una causa común de hipertensión secundaria y puede estar asociado a complicaciones cardiovasculares. Su diagnóstico se basa en la medición de aldosterona y renina en sangre y confirmación bioquímica, con posterior evaluación de localización, incluyendo, en la mayoría de los casos, cateterismo de venas suprarrenales para determinar la causa subyacente. Nuestro paciente constituye el cuarto caso publicado en la literatura sobre un quiste con sobreproducción hormonal confirmado bioquímicamente, lo cual es importante para no descartar la presencia de quistes como posible etiología de producción hormonal que, si bien no es lo más común, es posible encontrarlos.
- 10 April 2023
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 10 (2)
Open AccessHiperaldosteronismo causado por quiste adrenal
Introducción: los quistes adrenales son poco comunes, en especial los de tipo funcional, ya que solo se hallaron 3 casos reportados en la literatura. Objetivo: presentar un caso clínico de un paciente con hiperaldosteronismo asociado a un quiste adrenal. Presentación del caso: paciente masculino de 39 años con hipertensión arterial desde los 38 años al cual se le deciden realizar estudios de hipertensión secundaria, encontrando como hallazgo positivo hiperaldosteronismo primario en la evaluación inicial. Se realizó confirmación bioquímica con test de supresión con solución con un posterior hallazgo de adenoma adrenal izquierdo de baja densidad en TAC de abdomen contrastado, por lo que fue llevado a que se le realizara una adrenalectomía laparoscópica con curación bioquímica, según evaluación a los cuatro meses postoperatorios sin uso de antihipertensivos. Discusión y conclusión: los quistes adrenales generalmente se presentan unilateralmente con diferentes categorías histopatológicas, además, lo usual es que sean no funcionales. El hiperaldosteronismo primario es una causa común de hipertensión secundaria y puede estar asociado a complicaciones cardiovasculares. Su diagnóstico se basa en la medición de aldosterona y renina en sangre y confirmación bioquímica, con posterior evaluación de localización, incluyendo, en la mayoría de los casos, cateterismo de venas suprarrenales para determinar la causa subyacente. Nuestro paciente constituye el cuarto caso publicado en la literatura sobre un quiste con sobreproducción hormonal confirmado bioquímicamente, lo cual es importante para no descartar la presencia de quistes como posible etiología de producción hormonal que, si bien no es lo más común, es posible encontrarlos.
- Open Access
- 29 January 2023
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 9 (4) , 280-287
Facial nerve monitoring in parotid gland surgery: Design and feasibility assessment of a potential standardized technique
Background: Even though the use of nerve monitoring during parotid gland surgery is not the gold standard to prevent damage to the nerve, it surely offers some advantages over the traditional approach. Different from thyroid surgery, where a series of steps in intraoperative nerve monitoring have been described to confirm not only the integrity but—most importantly—the function of the recurrent laryngeal nerve, in parotid gland surgery, a formal guideline to follow while dissecting the facial nerve has yet to be described.Methods: A five‐year retrospective study was done reviewing the intraoperative records of patients who underwent parotid gland surgery under neural monitoring. The operative findings regarding the neuromonitoring process, particularly in regard to the amplitude of two main branches, were revised. A literature search was done to search for guidelines to follow when a facial nerve loss of signal is encountered.Results: Fifty‐five patients were operated on using the Nim 3 Nerve Monitoring System (Medtronic); 31 were female patients, and 47 patients had benign lesions. Minimum changes were observed in the amplitude records after a comparison was made between the first and the last stimulation. There were only three articles discussing the term loss of signal during parotid gland surgery.Conclusion: Today, no sufficient attention has been given to the facial nerve monitoring process during parotidectomy. This study proposes a formal guideline to follow during this procedure as well as an instruction to consider when a loss of signal is observed to develop a uniform technique of facial nerve stimulation
- 29 January 2023
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 9 (4) , 280-287
Open AccessFacial nerve monitoring in parotid gland surgery: Design and feasibility assessment of a potential standardized technique
Background: Even though the use of nerve monitoring during parotid gland surgery is not the gold standard to prevent damage to the nerve, it surely offers some advantages over the traditional approach. Different from thyroid surgery, where a series of steps in intraoperative nerve monitoring have been described to confirm not only the integrity but—most importantly—the function of the recurrent laryngeal nerve, in parotid gland surgery, a formal guideline to follow while dissecting the facial nerve has yet to be described.Methods: A five‐year retrospective study was done reviewing the intraoperative records of patients who underwent parotid gland surgery under neural monitoring. The operative findings regarding the neuromonitoring process, particularly in regard to the amplitude of two main branches, were revised. A literature search was done to search for guidelines to follow when a facial nerve loss of signal is encountered.Results: Fifty‐five patients were operated on using the Nim 3 Nerve Monitoring System (Medtronic); 31 were female patients, and 47 patients had benign lesions. Minimum changes were observed in the amplitude records after a comparison was made between the first and the last stimulation. There were only three articles discussing the term loss of signal during parotid gland surgery.Conclusion: Today, no sufficient attention has been given to the facial nerve monitoring process during parotidectomy. This study proposes a formal guideline to follow during this procedure as well as an instruction to consider when a loss of signal is observed to develop a uniform technique of facial nerve stimulation
- Open Access
- 3 January 2023
- Published by EDIMECO in Medicina y Laboratorio
- Vol. 27 (1) , 25-32
Lesiones metastásicas a glándula tiroides. Una serie de casos
Las lesiones metastásicas representan hasta un 3 % de los tumores malignos de la glándula tiroides. La mayoría de los casos se originan de tumores de células renales y de pulmón. El abordaje diagnóstico implica una alta sospecha clínica en pacientes con primarios conocidos, sin embargo, puede ser la manifestación inicial de una enfermedad maligna extensa no diagnosticada hasta en un 20 % a 40 % de los pacientes. La biopsia por aguja fina ha demostrado buen rendimiento para el diagnóstico de los nódulos metastásicos. El pronóstico y la opción del tratamiento quirúrgico dependen del control local del primario y del estado de la enfermedad sistémica asociada, por lo tanto, debe ser individualizado. Por lo general, hasta un 80 % de los pacientes con compromiso de la tiroides tienen enfermedad metastásica multiorgánica, y la intención del tratamiento quirúrgico es con fines paliativos para prevenir las complicaciones derivadas de la extensión local de la enfermedad a las estructuras del tracto aerodigestivo superior en el cuello. Se presenta a continuación, una serie de seis casos de pacientes con lesiones metastásicas a glándula tiroides con primarios en riñón, mama y de melanomas.
- 3 January 2023
- Published by EDIMECO in Medicina y Laboratorio
- Vol. 27 (1) , 25-32
Open AccessLesiones metastásicas a glándula tiroides. Una serie de casos
Las lesiones metastásicas representan hasta un 3 % de los tumores malignos de la glándula tiroides. La mayoría de los casos se originan de tumores de células renales y de pulmón. El abordaje diagnóstico implica una alta sospecha clínica en pacientes con primarios conocidos, sin embargo, puede ser la manifestación inicial de una enfermedad maligna extensa no diagnosticada hasta en un 20 % a 40 % de los pacientes. La biopsia por aguja fina ha demostrado buen rendimiento para el diagnóstico de los nódulos metastásicos. El pronóstico y la opción del tratamiento quirúrgico dependen del control local del primario y del estado de la enfermedad sistémica asociada, por lo tanto, debe ser individualizado. Por lo general, hasta un 80 % de los pacientes con compromiso de la tiroides tienen enfermedad metastásica multiorgánica, y la intención del tratamiento quirúrgico es con fines paliativos para prevenir las complicaciones derivadas de la extensión local de la enfermedad a las estructuras del tracto aerodigestivo superior en el cuello. Se presenta a continuación, una serie de seis casos de pacientes con lesiones metastásicas a glándula tiroides con primarios en riñón, mama y de melanomas.